The relative atherogenicity of VLDL and LDL is dependent on the topographic site[S]

To evaluate whether the relative atherogenicity of VLDL and LDL is dependent on the topographic site, atherosclerosis was compared at four topographic sites in homozygous LDL receptor (LDLr)-deficient rabbits fed normal chow and in heterozygous LDLr-deficient rabbits with the same genetic background...

Full description

Bibliographic Details
Published in:	Journal of Lipid Research
Main Authors:	Eline Van Craeyveld, Frank Jacobs, Yingmei Feng, Leen C.J. Thomassen, Johan A. Martens, Joke Lievens, Jan Snoeys, Bart De Geest
Format:	Article
Language:	English
Published:	Elsevier 2010-06-01
Subjects:	atherosclerosis lipoproteins topography rabbit apolipoprotein E familial hypercholesterolemia
Online Access:	http://www.sciencedirect.com/science/article/pii/S0022227520410223

Similar Items

The Differential Effects of HDL Subpopulations on Lipoprotein Lipase (LPL)-Mediated VLDL Catabolism
by: Ewa Wieczorek, et al.
Published: (2021-12-01)

Hypocholesterolemic effect of Cymbopogon citratus in Rabbits.
by: Wajeeh Y. AL-Ani
Published: (2013-11-01)

Relation of the size and intracellular sorting of apoB to the formation of VLDL 1 and VLDL 2
by: Pia Stillemark-Billton, et al.
Published: (2005-01-01)

Changes of Hematological and Hemorheological Parameters in Rabbits with Hypercholesterolemia
by: Bence Tanczos, et al.
Published: (2021-04-01)

Contribution of Rare and Common <i>APOE</i> Variants to Familial Hypercholesterolemia in Spanish Cohort
by: Lorena M. Vega-Prado, et al.
Published: (2025-01-01)

ACAT2 contributes cholesteryl esters to newly secreted VLDL, whereas LCAT adds cholesteryl ester to LDL in mice
by: Richard G. Lee, et al.
Published: (2005-06-01)

The effect of stomach’s different fullness levels on the topography of intestines in new zealand rabbit (oryctolagus cuniculus l.)
by: Özcan Özgel, et al.

The effect of the different strike levels of the stomach on the kidneys in the new zealand rabbit (oryctolagus cuniculus l.).
by: Özcan Özgel, et al.

Bergamot Reduces Plasma Lipids, Atherogenic Small Dense LDL, and Subclinical Atherosclerosis in Subjects with Moderate Hypercholesterolemia: a 6 Months Prospective Study
by: Peter P. eToth, et al.
Published: (2016-01-01)

Studies on the Effects of Hypercholesterolemia on Mouse Ophthalmic Artery Reactivity
by: Francesco Buonfiglio, et al.
Published: (2023-09-01)

Endogenous apoC-I increases hyperlipidemia in apoE-knockout mice by stimulating VLDL production and inhibiting LPL
by: Marit Westerterp, et al.
Published: (2006-06-01)

Hyperlipidemic Rabbit Models for Anti-Atherosclerotic Drug Development
by: Manabu Niimi, et al.
Published: (2020-12-01)

Ovarian expression of functional MTTP and apoB for VLDL assembly and secretion in chickens
by: Yu-Hui Chen, et al.
Published: (2025-05-01)

Genetically Modified Rabbits for Cardiovascular Research
by: Jianglin Fan, et al.
Published: (2021-02-01)

Electrochemical immunosensing of low-density lipoprotein based on sol-gel encapsulation
by: Elton Max Nascimento do Egito, et al.
Published: (2023-05-01)

SUBFRACTIONS OF ATHEROGENIC APOB-LIPOPROTEIDES IN PATIENTS WITH SEVERE HYPERCHOLESTEROLEMIA
by: E. A. Utkina, et al.
Published: (2017-08-01)

ANATOMICAL AND CT ANATOMICAL STUDY OF THE RABBIT LIVER IN DORSAL PLANES
by: R. Dimitrov
Published: (2021-06-01)

Molecular Regulation and Therapeutic Targeting of VLDL Production in Cardiometabolic DiseaseSummary
by: Kendall H. Burks, et al.
Published: (2025-01-01)

Case report: Unusual coexistence between familial hypercholesterolemia and familial hypobetalipoproteinemia
by: Kei Sasaki, et al.
Published: (2022-08-01)

Competing Genetic Traits and Their Influence on LDL Cholesterol Concentration in Familial Hypercholesterolemia
by: Christopher Song, MD, et al.
Published: (2024-01-01)

The evaluation and management of patients with LDL-C ≥ 190 mg/dL in a large health care system
by: Candace L. Jackson, et al.
Published: (2020-03-01)

Diallyl disulfide alleviates hypercholesterolemia induced by a western diet by suppressing endoplasmic reticulum stress in apolipoprotein E-deficient mice
by: Hyun Ju Kim, et al.
Published: (2023-05-01)

The LDL Apolipoprotein B-to-LDL Cholesterol Ratio: Association with Cardiovascular Mortality and a Biomarker of Small, Dense LDLs
by: Günther Silbernagel, et al.
Published: (2022-06-01)

Generation of hyperlipidemic rabbit models using multiple sgRNAs targeted CRISPR/Cas9 gene editing system
by: Tingting Yuan, et al.
Published: (2019-03-01)

Effect of Aqueous Extract of Walnut Leaves on Lipid Profile and Atherogenic Ratio in Hypercholesterolemic Rats
by: Rabia Azhar, Arif Siddiqui, Shazia Ali
Published: (2015-09-01)

Intensive Combination LDL-Lowering Therapy in a Patient With Homozygous Familial Hypercholesterolemia
by: Hayato Tada, MD, et al.
Published: (2024-06-01)

Mutation Analysis of the LDL Receptor Gene in Indian Families with Familial Hypercholesterolemia
by: Suyamindra S Kulkarni
Published: (2011-09-01)

Prevalence and penetrance of pathogenic and likely pathogenic LDLR and APOB gene variants linked to familial hypercholesterolemia and increased risk of ischemic heart disease
by: I. K. Dzhumaniiazova, et al.
Published: (2025-08-01)

Low dose of ROSuvastatin in combination with EZEtimibe effectively and permanently reduce low density lipoprotein cholesterol concentration independently of timing of administration (ROSEZE): A randomized, crossover study — preliminary results
by: Karolina Obońska, et al.
Published: (2021-02-01)

Low dose of ROSuvastatin in combination with EZEtimibe effectively and permanently reduce low density lipoprotein cholesterol concentration independently of timing of administration (ROSEZE): A randomized, crossover study — preliminary results
by: Karolina Obońska, et al.
Published: (2021-02-01)

Clinical characterization of familial hypercholesterolemia due to an amish founder mutation in Apolipoprotein B
by: Katie B. Williams, et al.
Published: (2022-03-01)

Topographic experiments over dynamical processes in the Norwegian Sea
by: Belonenko Tatyana V, et al.
Published: (2021-02-01)

Lipoprotein-X: A Case of Falsely Elevated LDL Hypercholesterolemia
by: Jacob Y. Mok, MD, et al.
Published: (2023-05-01)

The effect of 17β-estradiol plus norethisterone acetate treatment on lipoprotein (a), atherogenic and anti-atherogenic apolipoproteins levels in postmenopausal women: A meta-analysis of randomized controlled trials
by: Zengyao Tang, et al.
Published: (2023-02-01)

Evaluation of arterial stiffness in primary atherogenic dyslipidemias
by: Roopa Mehta, et al.
Published: (2024-04-01)

Functional characterization of 16 variants found in the LDL receptor gene
by: Kateřina Konečná, et al.
Published: (2025-09-01)

Analytical Validation of Familial Hypercholesterolemia Biomarkers in Dried Blood Spots
by: Patrice K. Held, et al.
Published: (2022-02-01)

Modified Diagnostic Criteria Tools for Familial Hypercholesterolemia without the Requirement for Clinical Genetic Testing: Rationale and Design of the MOOCS Adaptive Clinical Trial
by: Satyanarayana Upadhyayula
Published: (2024-10-01)

Identification of Known Mutation in LDL Receptor Gene Underlying Severe FH Phenotype in Thai Patient: A Case Report
by: Klai-upsorn S. Pongrapeeporn, et al.
Published: (2005-11-01)

Effect of Aerobic Exercise with and without Green Coffee Supplementation on Serum Apolipoprotein B and Atherogenic Indices of Overweight Men
by: Farida Fazel, et al.
Published: (2019-05-01)